July 17, 2013 / 4:12 PM / 4 years ago

Tigenix to raise 5 mln euros in private placement

BRUSSELS, July 17 (Reuters) - Belgian biotech group Tigenix will raise 5 million euros from an issue of new shares in a private placement, the group said on Wednesday.

Tigenix said it would use the proceeds to invest in the commercial launch of its main product ChondroCelect, which repairs damaged cartilage in the knee. (Reporting by Robert-Jan Bartunek)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below